It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
The aim is to strengthen industry-academia cooperation
Subscribe To Our Newsletter & Stay Updated
